Two strains of fastidious mycobacteria were isolated from two patients with AIDS and clinical disease suggestive of Mycobacterium avium complex infection. Acid-fast bacilli were isolated from blood and bone marrow of both patients in BACTEC 12B and/or 13A media. The acid-fast bacilli failed to grow on subculture to routine Lowenstein-Jensen medium containing pyruvate and egg yolk agar. After several attempts, the strain from one patient was finally cultured on Middlebrook 7H9 medium with agar, charcoal, and yeast extract 13 months after the initial specimens were received in the laboratory. The second patient's strain was cultured on the same medium 6 weeks postinoculation with fresh BACTEC fluid and 5 months after specimen collection. Routine biochemical and growth tests were performed on these isolates but failed to give definitive identifications. 16S rRNA gene sequencing suggested that the organisms share at least 98.9% homology with M. simiae. Even greater homology (99.86%) was found with the recently described species "M. genavense." Recognition of the fastidious nature of some mycobacteria that infect AIDS patients is important in the treatment of infections in these patients and in understanding the epidemiology of atypical mycobacterial infections. It is suggested that a liquid culture medium such as BACTEC be employed for primary isolation of mycobacteria from AIDS patients and that subculture to the charcoal medium described here be carried out for those organisms that fail to grow on subculture to routine media.
Disseminated mycobacterial infection is a well-documented opportunistic infection of patients with AIDS. Mycobacterium avium complex (MAC) organisms are responsible for most of these infections (5, 7) , although other species have been implicated, including M. tuberculosis, M. kansasii, M. haemophilum, and M. simiae (2, 4, 7, 11, 14) . Less commonly, M. gordonae, M. fortuitum, and M. chelonae have also been reported as causing disseminated mycobacterial infections in AIDS patients (7) . Patients with disseminated MAC infections may experience fever, malaise, weight loss, and other nonspecific symptoms and often fail to clear the organism despite antimycobacterial therapy (5) .
Hirschel et al. recently reported an infection with a novel unidentified organism resembling M. simiae which failed to grow on solid media but showed limited multiplication in BAClTEC liquid medium (6) . This patient had clinical signs and symptoms consistent with MAC infection. Bottger et al.
(1) also described disseminated infections in 18 patients infected with an organism that could not be grown on solid media. These strains had a unique 16S rRNA gene sequence and have been tentatively named "M. genavense." Here we report on the isolation of two strains of fastidious mycobacteria from two AIDS patients who also had clinical disease suggestive of MAC infection. These strains were both isolated in BACTEC broth cultures (Becton Dickinson, Sydney, Australia) and initially failed to grow on routine solid media. After several attempts, the organisms were cultured on Middlebrook 7H9 medium (Difco, Detroit, Mich.) containing agar, charcoal, and yeast extract. 
MATERIALS AND METHODS
Culture methods. Blood samples were collected in 5-ml volumes from each of these two patients and inoculated into BACTEC 13A bottles. Enrichment supplement (0.5 ml) containing 15% bovine serum albumin (Becton Dickinson) was aseptically added to each bottle. The bone marrow specimens were lysed with sterile distilled water and centrifuged at 2,500 x g for 20 min. The deposits (0.5 ml) were inoculated into BACT7EC 12B broths (Becton Dickinson) supplemented with polymyxin B, amphotericin B, nalidixic acid, trimethoprim, and azlocillin (PANTA; Becton Dickinson). The deposits (0.2 ml) were also cultured onto Lowenstein-Jensen medium containing 0.4% sodium pyruvate (LIP) and egg yolk agar (EYA), and a smear was prepared for Ziehl-Neelsen staining. The slopes were incubated at 31 and 36°C in air for 12 weeks and examined weekly. The BAC'TEC bottles were incubated at 36°C and read weekly by the BACTEC 460 TB instrument (Becton Dickinson) for 6 weeks and then again at 12 weeks. Cultures displaying positive growth readings were subcultured onto LJP and EYA, which were incubated at 36°C in air indefinitely. Smears were prepared for Ziehl-Neelsen staining, and NAP TB differentiation tests (Becton Dickinson) were performed to differentiate M. tuberculosis complex organisms from other mycobacteria.
As the AFB from both patients' specimens failed to grow on IJP and EYA, the BACTEC broths from patient 1 were subcultured at regular intervals onto a variety of media which were incubated at 36°C in a 5% carbon dioxide atmosphere. These included LJP, EYA, Herrold's medium containing mycobactin J, Middlebrook 7H10 medium (Difco) with 1.3% hemin, chocolate agar, Kirschner's broth, Middlebrook 7H10 medium supplemented with an autoclaved suspension of M. phlei, and Middlebrook 7H9 medium (Difco) containing 1.3% agar, 0.2% charcoal, and 1% yeast extract (7H9/CYE) (7H9/CYE can also be prepared by adding 2.5 g of Legionella CYE agar base [Oxoid] to 90 ml of Middlebrook 7H9 broth supplemented with 10 ml of ADC enrichment [Difco] ). The organism was kept viable by subculturing in BACTEC 12B broths. The isolate from patient 2 was subsequently subcultured onto LJP, EYA, LowensteinJensen medium-1% ferric ammonium citrate, and 7H9/CYE medium and incubated at 36°C in a 5% CO2 atmosphere.
Identification procedures. The AFB were identified by standard biochemical and growth tests (10) . A niacin test was performed with BACTEC 12B medium by using niacin test strips. The organisms were also probed with commercial DNA probes specific for M. tuberculosis complex and MAC organisms (Genprobe Inc., San Diego, Calif.). Drug susceptibility tests were performed by using MICs on Middlebrook 7H10 agar (3) after adaptation to growth on this medium.
Sequencing of 16S rRNA genes. The mycobacterial strains were grown in 20 ml of Middlebrook 7H9 broth, and the DNA was extracted as previously described (16) . The DNA pellets were suspended in sterile distilled water. The 16S rRNA genes were then amplified by polymerase chain reaction using oligonucleotide primers rRNA1 and rRNA2 ( cycles of 94°C for 1 min, 50°C for 1 min, and 72°C for 1 min. Following amplification, the polymerase chain reaction products were purified by high-performance liquid chromatography (15) and then sequenced by using the direct incorporation protocol of the finol DNA sequencing system (Promega) in accordance with the manufacturer's instructions. The sequencing primers MR1 to MR6 and rRNA2 (Table 1) were designed to read overlapping regions of the whole 16S rRNA gene. The 1,422 bases sequenced were then compared with known mycobacterial sequences by searching the GenBank data base (release 71).
RESULTS
The bone marrow specimens from both patients were negative for AFB on direct microscopy and on primary culture on solid media. The three blood cultures and the bone marrow BACTEC 12B broth culture from patient 1 showed positive growth readings of between 22 and 570 after 5 to 12 weeks of incubation. The bone marrow BACTEC 12B broth culture from patient 2 yielded a positive growth reading of 25 at week 6, and two of six blood cultures gave positive growth index values of 75 and 169 after 12 weeks of incubation. AFB were seen in smears from all of these BACT7EC cultures, and NAP TB differentiation tests gave results indicative of M. tuberculosis complex organisms. The AFB from all BACTEC cultures however, failed to grow on subculture to routine solid media (LJP and EYA). The AFB were kept viable by serial subculturing in BACTEC broths. Over a 7-month period, a variety of different media were inoculated with fresh BACTEC cultures and incubated in a 5% CO2 atmosphere. The strain from patient 1 was first cultured on solid medium (7H9/CYE) after 6 months of incubation at 36°C in a C02-enriched environment. The time from specimen receipt to growth on solid medium was The 16S rRNA sequences of the strains from both patients 1 and 2 are identical and are listed in GenBank (accession number, M95488). Results of a search through the GenBank data base confirmed that this organism is a Mycobacterium species and shares greatest homology (at least 98.9%) with M. simiae. The 1.1% variation in the sequence between M. simiae and the patients' strains is represented by 14 base substitutions, one deletion, and one insertion, and 13 bases were considered unreadable. Table 2 indicates the positions of these divergences. Comparison of the "M. genavense" 16S rRNA sequence listed in the EMBL data base (accession number, X60070) with that of the patient strains, however, demonstrated even greater homology (99.86%). The divergence from "M. genavense" is represented by a G deletion at position 186 and a T-for-G substitution at position 399 (position numbers are those found in the M. simiae sequence [GenBank accession number, X52931]), and 13 bases were unreadable.
DISCUSSION
The fastidious nature of some mycobacteria isolated from AIDS patients has been previously noted (6, 8, 9) . In 1990, we isolated a fastidious M. tuberculosis strain from an AIDS patient. The strain demonstrated a preference for broth culture and glycerophobicity when it was finally cultured on solid media (8) . We have also encountered a fastidious M. avium strain which was isolated from the blood of an AIDS patient. The organism grew proficiently in BACTEC 12B broth and was only cultured on a solid medium, Herrold's medium containing mycobactin J, 6 months after primary isolation (9). Hirschel et al. (6) M. simiae is an organism which has been found to be difficult to characterize fully, owing to poor reproducibility in standardized tests (11) . It may therefore be premature to draw conclusions about the definitive identity of the organism described in this study and whether it should be classified as a new species or subspecies of mycobacterium. Further characterization is required, with particular reference to the methods described by Levy-Frebault and Portaels (12) , and this work is currently being undertaken.
We were fortunate that, unlike the strains described by Bottger et al. (1) and Hirschel et al. (6) , the organisms reported here were culturable on solid media after extended incubation. The usefulness of incorporating charcoal to absorb toxic substances and yeast extract to provide additional nutrients in media for fastidious mycobacteria should be understated. It is possible that the strain from patient 1 adapted to laboratory growth after more than 1 year of repeated subculture in broth. The strain from patient 2, however, was cultured well before the strain from patient 1 (6 weeks postinoculation) on 7H9/CYE agar after initial failure to grow on routine LJP and EYA.
The two strains were later cultured on media with and without charcoal and yeast extract to determine whether one or both of these additives enhance growth. However, by this time, both strains had adapted to growth on Middlebrook 7H10 without charcoal and yeast extract. It is therefore recommended that both ingredients be included in the medium for isolation.
It is expected that we will continue to encounter new or fastidious strains of mycobacteria in AIDS patients. Immune suppression predisposes these patients to infection with organisms that may be less virulent or unable to cause disease in normal, healthy people. The AFB isolated from both patients in this study were 
